NCT02315248View on ClinicalTrials.gov

Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study

CompletedOBSERVATIONAL
Enrollment

197

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Osteoporosis
Interventions
RADIATION

Quantitative computed tomography scan for bone density analysis

A low radiation dose quantitative computed tomography (QCT) of the spine (L1 and L2) and the hips will be performed to measure bone density in the spine and hips.

Trial Locations (1)

39216

University of Mississippi Medical Center, Jackson

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

University of Mississippi Medical Center

OTHER

NCT02315248 - Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study | Biotech Hunter | Biotech Hunter